ISSN: 2165-7904

Zeitschrift für Adipositas- und Gewichtsverlusttherapie

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Indiziert in
  • Index Copernicus
  • Google Scholar
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Zentrum für Landwirtschaft und Biowissenschaften International (CABI)
  • RefSeek
  • Hamdard-Universität
  • EBSCO AZ
  • OCLC – WorldCat
  • SWB Online-Katalog
  • CABI-Volltext
  • Direkte Kabine
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • Universität Bristol
  • veröffentlicht
  • ICMJE
Teile diese Seite

Abstrakt

Analysis for the Success Rate of Patients after Laparoscopic Sleeve Gastrectomy

Jose Baptista*, Vanessa Praxedes, Ana André, Edgar Rosa, Carlos Trindade and Luis Cortez

Background: Success rate of laparoscopic sleeve gastrectomy (SG) depends on disease and patient characteristics that are yet to be fully established.
Objectives: To evaluate which patient characteristics influence the success of SG.
Setting: National bariatric reference centre at a Public Hospital.
Methods: A retrospective study was performed based on prospectively collected data of patients who had bariatric surgery at our institution, during a 5 year period. Patients with 12 or more months of follow-up were included. We analyzed data from 133 SG. Seventy-nine percent of the patients were female with a median age of 46 years, a median baseline Body Mass Index (BMI) of 41 kg/m2 and a mean of 2.5 out of 7 comorbidities.
Results: After the first year, the mean percentage Excess Weight Loss (%EWL) was 69.3%, the mean change in BMI was -11.8 kg/m2 and the mean % total body weight loss was 27.4%. Surgical success (%EWL ≥ 50%) was achieved in 82% of the patients, with significant improvement or resolution of comorbidities (follow-up rate 76%-88%). We found statistical significant differences with baseline BMI (p<0.0001), with OSA (p<0.0001), with age (p=0.04) and with the number of comorbidities (p=0.05). Higher baseline characteristics implicated less %EWL. The presence of HTN or arthropathy and being a volume eater or a sweet eater did not influence surgical success (χ2 ≤ 0.01).
Conclusions: SG is an effective surgical treatment for obesity. After one year the majority of patients had surgical success and major comorbidities were mitigated or resolved. Success was influenced by specific patient and disease characteristics.